| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Shilpa Medicare Limited (NSE: SHILPAMED)
SHILPAMED Technical Analysis
5
| As on 25th Apr 2024 SHILPAMED SHARE Price closed @ 530.90 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 356.85 & Strong Buy for SHORT-TERM with Stoploss of 447.24 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SHILPAMEDSHARE Price
| Open | 531.00 | Change | Price | % |
| High | 533.70 | 1 Day | -0.20 | -0.04 |
| Low | 527.25 | 1 Week | 6.45 | 1.23 |
| Close | 530.90 | 1 Month | 80.70 | 17.93 |
| Volume | 123694 | 1 Year | 276.15 | 108.40 |
| 52 Week High 496.65 | 52 Week Low 228.20 | ||||
NSE INDIA Most Active Stocks
| IDEA | 13.90 | 6.11% |
| YESBANK | 25.95 | 1.96% |
| KOTAKBANK | 1642.45 | -10.87% |
| SOUTHBANK | 30.40 | 4.47% |
| SAIL | 164.95 | 0.18% |
| PNB | 135.90 | 2.18% |
| TATASTEEL | 167.70 | 1.30% |
| AXISBANK | 1127.00 | 6.00% |
| IRFC | 150.25 | 0.84% |
| IOB | 66.90 | 5.77% |
NSE INDIA Top Gainers Stocks
| ROML | 75.65 | 19.98% |
| POWERINDIA | 9329.50 | 13.60% |
| GPTINFRA | 211.80 | 12.51% |
| NEOGEN | 1557.75 | 12.25% |
| PNC | 65.00 | 11.02% |
| PNC | 65.00 | 11.02% |
| PNC | 65.00 | 11.02% |
| PNC | 65.00 | 11.02% |
| MOIL | 430.70 | 10.88% |
| GODFRYPHLP | 3449.70 | 10.17% |
NSE INDIA Top Losers Stocks
| SHILPAMED Daily Charts |
SHILPAMED Intraday Charts |
Whats New @ Bazaartrend |
SHILPAMED Free Analysis |
|
|
SHILPAMED Important Levels Intraday
| RESISTANCE | 543.33 |
| RESISTANCE | 539.34 |
| RESISTANCE | 536.88 |
| RESISTANCE | 534.42 |
| SUPPORT | 527.38 |
| SUPPORT | 524.92 |
| SUPPORT | 522.46 |
| SUPPORT | 518.47 |
SHILPAMED Target April 2024
| 4th UP Target | 686.57 |
| 3rd UP Target | 600.86 |
| 2nd UP Target | 547.87 |
| 1st UP Target | 494.89 |
| 1st DOWN Target | 343.71 |
| 2nd DOWN Target | 290.73 |
| 3rd DOWN Target | 237.74 |
| 4th DOWN Target | 152.03 |
SHILPAMED Weekly Target
| 4th UP Target | 671.17 |
| 3rd UP Target | 627.36 |
| 2nd UP Target | 600.27 |
| 1st UP Target | 573.19 |
| 1st DOWN Target | 495.91 |
| 2nd DOWN Target | 468.83 |
| 3rd DOWN Target | 441.74 |
| 4th DOWN Target | 397.93 |
SHILPAMED Target2024
| 4th UP Target | 720.32 |
| 3rd UP Target | 595.24 |
| 2nd UP Target | 517.92 |
| 1st UP Target | 440.61 |
| 1st DOWN Target | 219.99 |
| 2nd DOWN Target | 142.68 |
| 3rd DOWN Target | 65.36 |
| 4th DOWN Target | -59.72 |
Shilpa Medicare Limited ( NSE INDIA Symbol : SHILPAMED )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SHILPAMED Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
| 200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is 32.14 | Sideways | |
| MFI (14) | MFI is 26.05 | Sideways | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is Below -80 | Over Sold | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 452.44 | |
| 10 Day Avg Volume | Traded -91.38 % Less then 10 Day Average Volume | ||
SHILPAMED Other Details
| Segment | EQ | |
| Market Capital | 49323773952.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > | |
SHILPAMED Address
 |
||
SHILPAMED Latest News
SHILPAMED Business Profile
Shilpa Medicare Limited, together with its subsidiaries, engages in the manufacturing and selling active pharmaceutical ingredients (API's), intermediates, and formulations in India, the United States, Europe, and internationally. It offers oncology and non-oncology API's.; and new drug delivery systems, peptides/biotech products, specialty chemicals, etc. The company also provides contract manufacturing of various dosage forms, such as tablets, capsules, liquid injections, lyophilized injectables, and sterile dry powder injectables. It is also involved in the wind power generation activities. Shilpa Medicare Limited was incorporated in 1987 and is headquartered in Raichur, India. Address: Shilpa House, Raichur, India, 584135
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service